CD34 and atherosclerosis: Circulating progenitor cells (CD34+CPCs), including a cell subset defined as endothelial progenitor cells (EPCs),are recognised to contribute to postnatal vasculogenesis and to endothelial homeostasis,delaying the development of atherosclerosis and cardiovascular disease (CVD)[1].